Truist Financial Issues Pessimistic Forecast for Astrana Health (NASDAQ:ASTH) Stock Price

Astrana Health (NASDAQ:ASTH - Get Free Report) had its price objective dropped by equities researchers at Truist Financial from $50.00 to $46.00 in a research note issued on Tuesday,Benzinga reports. The brokerage currently has a "buy" rating on the stock. Truist Financial's price objective would suggest a potential upside of 48.92% from the stock's previous close.

A number of other analysts have also commented on ASTH. Stifel Nicolaus reduced their price objective on shares of Astrana Health from $70.00 to $56.00 and set a "buy" rating for the company in a research note on Thursday, February 20th. Macquarie raised shares of Astrana Health to a "hold" rating in a research note on Monday, December 16th. Bank of America dropped their target price on Astrana Health from $55.00 to $49.00 and set a "buy" rating on the stock in a report on Tuesday, March 4th. Finally, Robert W. Baird dropped their target price on Astrana Health from $86.00 to $50.00 and set an "outperform" rating on the stock in a report on Monday, March 3rd. Two investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $56.17.

Astrana Health Price Performance

ASTH stock traded up $0.07 during trading on Tuesday, hitting $30.89. The company had a trading volume of 679,468 shares, compared to its average volume of 255,139. The firm has a market capitalization of $1.74 billion, a price-to-earnings ratio of 23.76, a P/E/G ratio of 1.37 and a beta of 1.30. The business has a 50 day moving average of $33.97 and a 200 day moving average of $42.52. Astrana Health has a fifty-two week low of $23.12 and a fifty-two week high of $63.20. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60.

Remove Ads

Astrana Health (NASDAQ:ASTH - Get Free Report) last issued its quarterly earnings results on Thursday, February 27th. The company reported ($0.15) earnings per share for the quarter, missing analysts' consensus estimates of $0.22 by ($0.37). Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The business had revenue of $665.21 million during the quarter, compared to analyst estimates of $617.24 million. As a group, research analysts predict that Astrana Health will post 1.15 earnings per share for the current year.

Institutional Trading of Astrana Health

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Handelsbanken Fonder AB increased its stake in shares of Astrana Health by 4.7% in the fourth quarter. Handelsbanken Fonder AB now owns 8,900 shares of the company's stock valued at $281,000 after buying an additional 400 shares in the last quarter. Quarry LP increased its stake in shares of Astrana Health by 35.5% in the fourth quarter. Quarry LP now owns 1,799 shares of the company's stock valued at $57,000 after buying an additional 471 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Astrana Health by 3.9% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 24,505 shares of the company's stock valued at $773,000 after buying an additional 915 shares in the last quarter. Swiss National Bank increased its stake in shares of Astrana Health by 1.1% in the fourth quarter. Swiss National Bank now owns 88,444 shares of the company's stock valued at $2,789,000 after buying an additional 1,000 shares in the last quarter. Finally, MetLife Investment Management LLC increased its position in Astrana Health by 4.7% in the fourth quarter. MetLife Investment Management LLC now owns 26,284 shares of the company's stock worth $829,000 after purchasing an additional 1,173 shares during the period. 52.77% of the stock is currently owned by institutional investors and hedge funds.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.